Symptoms | Nonsurvivors (n = 14) |
---|---|
Fever | 11 (78.6%) |
Cough | 12 (85.7%) |
Sputum production | 4 (28.6%) |
Dyspnea | 10 (71.4%) |
Myalgia | 0 |
Chest tightness | 2 (14.3%) |
Headache | 1 (7.1%) |
Diarrhea | 4 (28.6%) |
Blood pressure | |
Systolic, mm Hg | 133.5 (16.0) |
Diastolic, mm Hg | 78.1 (10.7) |
Laboratory resultsa | |
Leukocytes (3.5–9.5), × 109/L, | 9.9 (3.0) |
Lymphocyte count (1.1–3.2), × 109/L, | 0.6 (0.3) |
Neutrophils (1.8–6.3), × 109/L | 9.2 (2.9) |
C-reactive protein (≤6.0), × 109/L | 156.8 (75.5) |
Treatment | |
High-flow nasal cannula | 14 (100%) |
Mechanical ventilation | |
Noninvasive | 9 (64.3%) |
Invasive | 3 (21.4%) |
Antiviral agents | 14 (100%) |
Antibacterial agents | 13 (92.9%) |
Antifungal agents | 1 (7.1%) |
Glucocorticoids | 10 (71.4%) |
Immunoglobulin | 5 (35.7%) |
α-IFN | 4 (28.6%) |
Renal replacement therapy | 4 (28.6%) |
Comorbidities | |
Acute respiratory distress syndrome | 13 (92.9%) |
Acute kidney injury | 3 (21.4%) |
Liver dysfunction | 3 (21.4%) |
Cardiac injury | 4 (28.6%) |
Hyperglycemia | 1 (7.1%) |
Multiple organ dysfunction syndrome | 2 (14.3%) |
Bacteremia | 2 (14.3%) |
Fungal septicemia | 1 (7.1%) |